By Regulatory Approvals — FDA Approves Shorter Monitoring for First Two Tarlatamab Doses in ES-SCLC CancerNetwork
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 15, 2026.